![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Division of Molecular Toxicology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.A., Y.H., Å.N., S.N.,T.B.A., M.I.-S., I.J.); and Drug Metabolism and Pharmacokinetics & Bioanalytical Chemistry, AstraZeneca R&D Mölndal, Mölndal, Sweden (X.L.,T.B.A.)
The enzymic basis for intracellular reduction of N-hydroxylated amidines to their corresponding amidines, and hydroxylamines to their corresponding amines, is unknown. The hydroxylated amidines can be used as prodrug moieties, and an understanding of the enzyme system active in the reduction can contribute to more efficient drug development. In this study, we examined the properties of this enzyme system using benzamidoxime and N-hydroxymelagatran as substrates. In rats and humans, the hepatic enzyme system was localized in mitochondria as well as in microsomes, using preferably NADH as cofactor. Potassium cyanide, N-methylhydroxylamine, p-hydroxymercuribenzoate, and desferrioxamine were efficient inhibitors, whereas typical cytochrome P450 (P450) inhibitors were ineffective. In rats, the highest specific activity was found in liver, adipose tissue, and kidneys, whereas in humans, the specific activity in the preparations of adipose tissue examined was lower. A sex difference was observed in rat liver, where 4-fold higher activity was seen in microsomes from female rats. No gender differences were present in any other tissue investigated. Partial purification of the hepatic system was achieved using polyethylene glycol fractionation followed by Octyl Sepharose chromatography at low detergent concentrations, whereas the enzyme was denatured after complete solubilization. The unique appearance of the enzyme activity in adipose tissue, together with the cyanide sensitivity and the failure of typical P450 inhibitors to impede the reaction, indicates that the enzyme system active in reduction of benzamidoxime and N-hydroxymelagatran formation is not of cytochrome P450 origin, but likely consists of an NADH-dependent electron transfer chain with a cyanide-sensitive protein as the terminal component.
This article has been cited by other articles:
|
|
 |
|
  E. Sjogren, H. Lennernas, T. B. Andersson, J. Grasjo, and U. Bredberg The Multiple Depletion Curves Method Provides Accurate Estimates of Intrinsic Clearance (CLint), Maximum Velocity of the Metabolic Reaction (Vmax), and Michaelis Constant (Km): Accuracy and Robustness Evaluated through Experimental Data and Monte Carlo Simulations Drug Metab. Dispos., January 1, 2009; 37(1): 47 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sjodin, H. Fritsch, U. G. Eriksson, U. Logren, A. Nordgren, P. Forsell, L. Knutson, and H. Lennernas Intestinal and Hepatobiliary Transport of Ximelagatran and Its Metabolites in Pigs Drug Metab. Dispos., August 1, 2008; 36(8): 1519 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Havemeyer, F. Bittner, S. Wollers, R. Mendel, T. Kunze, and B. Clement Identification of the Missing Component in the Mitochondrial Benzamidoxime Prodrug-converting System as a Novel Molybdenum Enzyme J. Biol. Chem., November 17, 2006; 281(46): 34796 - 34802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Saulter, J. R. Kurian, L. A. Trepanier, R. R. Tidwell, A. S. Bridges, D. W. Boykin, C. E. Stephens, M. Anbazhagan, and J. E. Hall UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE Drug Metab. Dispos., December 1, 2005; 33(12): 1886 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Clement, S. Mau, S. Deters, and A. Havemeyer Drug Metab. Dispos., November 1, 2005; 33(11): 1740 - 1747. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
